| Literature DB >> 35049660 |
Evelina I Nikelshparg1, Adil A Baizhumanov1, Zhanna V Bochkova1, Sergey M Novikov2, Dmitry I Yakubovsky2, Aleksey V Arsenin2, Valentyn S Volkov2, Eugene A Goodilin3,4, Anna A Semenova3, Olga Sosnovtseva5, Georgy V Maksimov1,6, Nadezda A Brazhe1.
Abstract
Surface-enhanced Raman spectroscopy (SERS) is a promising tool that can be used in the detection of molecular changes triggered by disease development. Cardiovascular diseases (CVDs) are caused by multiple pathologies originating at the cellular level. The identification of these deteriorations can provide a better understanding of CVD mechanisms, and the monitoring of the identified molecular changes can be employed in the development of novel biosensor tools for early diagnostics. We applied plasmonic SERS nanosensors to assess changes in the properties of erythrocytes under normotensive and hypertensive conditions in the animal model. We found that spontaneous hypertension in rats leads (i) to a decrease in the erythrocyte plasma membrane fluidity and (ii) to a decrease in the mobility of the heme of the membrane-bound hemoglobin. We identified SERS parameters that can be used to detect pathological changes in the plasma membrane and submembrane region of erythrocytes.Entities:
Keywords: biosensing; erythrocytes; hemoglobin; nanoparticles; plasma membrane; plasmonic nanostructures; spontaneously hypertensive rats; surface-enhanced Raman spectroscopy
Mesh:
Substances:
Year: 2022 PMID: 35049660 PMCID: PMC8773528 DOI: 10.3390/bios12010032
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1Schematic illustration of (a) the experimental design and (b) cross-sections of an erythrocyte and an erythrocyte ghost demonstrating the non-homogeneity of hemoglobin molecules in the submembrane region of erythrocytes and the homogeneity of hemoglobin bound to AE1-exchanger in erythrocyte ghosts-enclosed vesicles of erythrocyte plasma membrane.
Figure 2Characterization of plasmonic nanostructured surfaces. (a) SEM image of AgNSS; (b) topographical (AFM) image of AgNSS aggregates; (c) typical pseudo-color s-SNOM image (5 × 5 μm2) of Ag nanoparticles obtained at the wavelength λ = 720 nm. The color scale (c) shows the optical near-field intensity in arbitrary units.
Figure 3Hypertension-related effects. (a) SERS spectra of erythrocyte ghosts and erythrocytes from WKY rats and SHR in the low-frequency region. Spectra are normalized by the intensity of the peak at 1375 cm−1. Spectra are shifted vertically for a better presentation. Numbers above peaks correspond to the peak positions (in cm−1). Scale 0.5 a. u. (b) The ratio I1638/I1375 (the probability of the planar heme conformation) and (c) the ratio I1175/I1375 (in-plane heme mobility) calculated from the SERS spectra of erythrocytes and erythrocyte ghosts from WKY rats (grey boxes) and SHR (red boxes). * p < 0.05; # p = 0.0556 (Mann-Whitney test). (d) SERS spectra of erythrocyte ghosts from WKY rats (gray) and SHR (red) in the high-frequency region. Spectra are normalized by the intensity of the peak 2927 cm−1. Numbers above peaks correspond to the peak positions (in cm−1). Scale 0.2 a. u. (e) The ratio I2872/I2927 reflects the ordering of the lipid phase in the membrane of erythrocyte ghosts. * p < 0.05 (Mann-Whitney test).
Figure 4Correlations between different SERS parameters. (a–c) Correlations between arterial blood pressure (ABP) (x-axis) and the ratios (y-axis) of peak intensities in the SERS spectra of erythrocyte ghosts from WKY (squares) and SHR (circles) rats. (d) Correlation between the ratios corresponding to in-plane Hb heme mobility and the stiffness of plasma membrane of erythrocyte ghosts. Sp, Spearman correlation coefficient.
SERS peak assignment [12,27,28,36].
| Peak Position (cm−1) | Assignment | Main Contribution from Molecules: |
|---|---|---|
| 1121 | Cb–CH3 | HbO2 |
| 1175 | Pyrrole half-ring, asymmetric | HbO2 |
| 1375 | Pyrrole half-ring, symmetric | HbO2 |
| 1638 | CaCm, CaCmH, CaCb | HbO2 in planar conformation |
| 2872 | νas ( =CH2) | lipids in trans conformation and cholesterol |
| 2927 | νs (–CH3) | lipids and proteins |
| 2962 | νas (–CH3) | lipids and proteins |